Acute Respiratory Distress Syndrome Market Size, Share, Growth, Opportunities And Business Challenges 2030
Acute Respiratory Distress Syndrome Market - By Type, By Cause, By Device Type, By Injury, By Route Of Administration, By End-User Industry, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
| Published: Oct-2022 | Report ID: HLCA2212 | Pages: 1 - 206 | Formats*: |
| Category : Healthcare | |||
Acute Respiratory Distress Syndrome Market Introduction and Overview
According to SPER Market Research, the Global Acute Respiratory Distress Syndrome Market is estimated to reach 5.42 Billion by 2032 with a CAGR of 5.94%.
The report includes an in-depth analysis of the Global Acute Respiratory Distress Syndrome Market, including market size and trends, product mix, Applications, and supplier analysis. A potentially lethal lung damage that results in fluid seeping into the lungs is called acute respiratory distress syndrome (ARDS). Most people who have ARDS are already in the hospital getting better following an injury or receiving treatment. Alveoli, the lungs' tiny, elastic air sacs, are where fluids usually build up and cause the condition. This fluid buildup results in less oxygen reaching the bloodstream. The consequence is that the organs are not getting enough oxygen to function properly. People with various conditions will develop acute respiratory distress syndrome (ARDS) a few hours to many days after the original injury or infection.
- In 2021- Announcing the launch of the SonarMed airway monitoring system was Medtronic. The endotracheal tube occlusion is detected by means of acoustic technology in this system. This has led to a growth in the company's product portfolio.
- In 2020- According to F. Hoffman-La Roche Ltd., the SARS-CoV-2 rapid antibody test was available. The investigation was initiated in collaboration with SD Biosensor, Inc. This has led to a growth in the company's product portfolio.
-007110521052024.webp)
Market Opportunities and Challenges
Opportunities: Diagnoses are becoming more and more necessary, which is driving up the market. According to market predictions, the diagnosis industry will dominate because many patients need many diagnoses to complete their therapy in a timely manner. The market has a ton of opportunities as a result. To educate the public on the variety of diagnosis and treatments that are available, several governments are launching awareness programs. Reputable manufacturers have released several products with enhanced functionality. One example is the SonarMed airway monitoring device, which was released according to Medtronic. This gadget monitors for endotracheal tube occlusion using acoustic technology. This quickens the growth of the market.
Challenges: Throughout the projected period, a shortage of competent professionals who are unaware of the available treatment choices for respiratory distress syndrome may hinder the growth of the global market for respiratory distress syndrome treatments. Prescription costs are increasing concurrently with an increase in the incidence of diseases. The market's growth is being hindered by the rising costs of therapy. ICU nurses encounter numerous obstacles and strict regulations for clearance, which pose a major market challenge for the worldwide acute respiratory distress syndrome (ARDS) market. ARDS treatment complications and high equipment and therapy costs, on the other hand, are hindering the growth of the acute respiratory distress syndrome (ARDS) market globally.
-007105321052024.webp)
Market Competitive Landscape
The competitive landscape of the acute respiratory distress syndrome (ARDS) market includes information broken down by competitor. In-depth information is provided about the company's background, finances, revenue, market potential, R&D spending, new market initiatives, global reach, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product breadth and width, and application dominance. Key players are Armstrong Medical, Besmed Health Business Corp, Bayer AG, Drägerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, and Pfizer Inc are a few of the top companies in the sector.
Scope of the report
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type, By Cause, By Route of Administration, By End-User Industry, By Distribution Channel |
| Geographies covered | North America, Asia-Pacific, Latin America, Middle East &Africa and Europe |
| Companies Covered | Armstrong Medical, Besmed Health Business Corp, Bayer AG, Drägerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, Pfizer Inc. |
COVID-19 Impact on Global Acute Respiratory Distress Syndrome Market
The COVID-19 pandemic had an impact on the world economy. The disease was extremely common and infectious throughout the pandemic and even in the post-pandemic era, which led to the progressive development of respiratory disorders like pneumonia and acute respiratory distress syndrome. Consequently, the global market for respiratory distress syndrome medications had a notable surge following the COVID-19 pandemic. The global healthcare and pharmaceutical industries have been greatly impacted by the COVID-19 pandemic. Regarding the ARDS market, this epidemic has been extremely beneficial. Furthermore, contributing to the market's expansion has been the public's growing awareness of ARDS because of this outbreak.
Key Target Audience
- Hospitals and Critical Care Units
- Pulmonologists and Intensivists
- Respiratory Therapists
- Nurses
- Medical Device Manufacturers
- Pharmaceutical Companies
- Government Agencies
- Research Institutions and Academia
- Patient Advocacy Groups
- Investors and Venture Capitalists
Our in-depth analysis of the Acute Respiratory Distress Syndrome Market includes the following segments:
| By Type: |
|
| By Cause: |
|
| By Route of Administration: |
|
| By End-user Industry: |
|
| By Distribution Channel: |
|
Key Topics Covered in the Report
- Global Acute Respiratory Distress Syndrome Market Size (FY’2022-FY’2032)
- Overview of Global Acute Respiratory Distress Syndrome Market
- Segmentation of Global Acute Respiratory Distress Syndrome Market By Type (Diagnosis, Treatment)
- Segmentation of Global Acute Respiratory Distress Syndrome Market By Cause (Coronavirus Disease 2019 (COVID-19), Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, Others)
- Segmentation of Global Acute Respiratory Distress Syndrome Market By Route of Administration (Oral, Parenteral, Intramuscular, Intravenous, Others)
- Segmentation of Global Acute Respiratory Distress Syndrome Market By End-user Industry (Hospitals, Specialty Clinics, Home Healthcare, Others)
- Segmentation of Global Acute Respiratory Distress Syndrome Market By Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy,
- Others)
- Statistical Snap of Global Acute Respiratory Distress Syndrome Market
- Expansion Analysis of Global Acute Respiratory Distress Syndrome Market
- Problems and Obstacles in Global Acute Respiratory Distress Syndrome Market
- Competitive Landscape in the Global Acute Respiratory Distress Syndrome Market
- Impact of COVID-19 and Demonetization on Global Acute Respiratory Distress Syndrome Market
- Details on Current Investment in Global Acute Respiratory Distress Syndrome Market
- Competitive Analysis of Global Acute Respiratory Distress Syndrome Market
- Prominent Players in the Global Acute Respiratory Distress Syndrome Market
- SWOT Analysis of Global Acute Respiratory Distress Syndrome Market
- Global Acute Respiratory Distress Syndrome Market Future Outlook and Projections (FY’2022-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Acute Respiratory Distress Syndrome Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Acute Respiratory Distress Syndrome Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Acute Respiratory Distress Syndrome Market
7. Global Acute Respiratory Distress Syndrome Market, By Type (USD Million) 2019-2032
7.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Type, 2019-20257.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Type, 2026-20327.3. Diagnosis7.4. Treatment
8. Global Acute Respiratory Distress Syndrome Market, By Cause (USD Million) 2019-2032
8.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Cause, 2019-20258.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Cause, 2026-20328.3. Coronavirus Disease 2019 (COVID-19)8.4. Sepsis8.5. Inhalation of Harmful Substances8.6. Severe Pneumonia8.7. Others
9. Global Acute Respiratory Distress Syndrome Market, By Route of Administration (USD Million) 2019-2032
9.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Route of Administration, 2019-20259.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Route of administration, 2026-20329.3. Oral9.4. Parenteral9.5. Intramuscular9.6. Intravenous9.7. Others
10. Global Acute Respiratory Distress Syndrome Market, By End-user Industry (USD Million) 2019-2032
10.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By End-user Industry, 2019-202510.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By End-user Industry, 2026-203210.3. Hospitals10.4. Specialty Clinics10.5. Home Healthcare10.6. Others
11. Global Acute Respiratory Distress Syndrome Market, By Distribution Channel (USD Million) 2019-2032
11.1. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Distribution Channel, 2019-202511.2. Global Acute Respiratory Distress Syndrome Market Size, Share and Forecast, By Distribution Channel, 2026-203211.3. Direct Tender11.4. Hospital Pharmacy11.5. Retail Pharmacy11.6. Online Pharmacy11.7. Others
12. Global Acute Respiratory Distress Syndrome Market Forecast, 2019-2032 (USD Million)
12.1. Global Acute Respiratory Distress Syndrome Market Size and Market Share
13. Global Acute Respiratory Distress Syndrome Market, By Region, 2019-2032 (USD Million)
13.1. Global Acute Respiratory Distress Syndrome Market Size and Market Share By Region (2019-2025)13.2. Global Acute Respiratory Distress Syndrome Market Size and Market Share By Region (2026-2032)13.3. Asia-Pacific
13.3.1. Australia13.3.2. China13.3.3. India13.3.4. Japan13.3.5. South Korea13.3.6. Rest of Asia-Pacific
13.4. Europe
13.4.1. France13.4.2. Germany13.4.3. Italy13.4.4. Spain13.4.5. United Kingdom13.4.6. Rest of Europe
13.5. Middle East and Africa
13.5.1. Kingdom of Saudi Arabia13.5.2. United Arab Emirates13.5.3. Qatar13.5.4. South Africa13.5.5. Egypt13.5.6. Morocco13.5.7. Nigeria13.5.8. Rest of Middle-East and Africa
13.6. North America
13.6.1. Canada13.6.2. Mexico13.6.3. United States
13.7. Latin America
13.7.1. Argentina13.7.2. Brazil13.7.3. Rest of Latin America
14. Company Profile
14.1. Armstrong Medical
14.1.1. Company details14.1.2. Financial outlook14.1.3. Product summary14.1.4. Recent developments
14.2. Besmed Health Business Corp.
14.2.1. Company details14.2.2. Financial outlook14.2.3. Product summary14.2.4. Recent developments
14.3. Bayer AG
14.3.1. Company details14.3.2. Financial outlook14.3.3. Product summary14.3.4. Recent developments
14.4. Drägerwerk AG & Co. KGaA.
14.4.1. Company details14.4.2. Financial outlook14.4.3. Product summary14.4.4. Recent developments
14.5. EUROSETS
14.5.1. Company details14.5.2. Financial outlook14.5.3. Product summary14.5.4. Recent developments
14.6. Fisher & Paykel Healthcare Limited
14.6.1. Company details14.6.2. Financial outlook14.6.3. Product summary14.6.4. Recent developments
14.7. F. Hoffmann-La Roche Ltd
14.7.1. Company details14.7.2. Financial outlook14.7.3. Product summary14.7.4. Recent developments
14.8. Getinge AB
14.8.1. Company details14.8.2. Financial outlook14.8.3. Product summary14.8.4. Recent developments
14.9. LivaNova PLC
14.9.1. Company details14.9.2. Financial outlook14.9.3. Product summary14.9.4. Recent developments
14.10. Pfizer Inc.
14.10.1. Company details14.10.2. Financial outlook14.10.3. Product summary14.10.4. Recent developments
14.11. Others
15. Conclusion
16. List of Abbreviation
17. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
The Acute Respiratory Distress Syndrome Market is projected to reach USD 5.42 billion by 2032, growing at a CAGR of 5.94% during the forecast period.
The Acute Respiratory Distress Syndrome Market grew in market size from 2021. The Market is expected to reach USD 5.42 billion by 2032, at a CAGR of 5.94% during the forecast period.
The Acute Respiratory Distress Syndrome Market CAGR of 5.94% during the forecast period.
You can get the sample pages by clicking the link - Click Here
The Acute Respiratory Distress Syndrome Market size is USD 5.42 billion from 2022 to 2032.
The Acute Respiratory Distress Syndrome Market segment is Covered By Type, By Cause, By Route of Administration, By End-User Industry, By Distribution Channel.
The North America region is anticipated to have the highest market share in the Acute Respiratory Distress Syndrome Market.
The key players in the market include Companies Covered Armstrong Medical, Besmed Health Business Corp, Bayer AG, Drägerwerk AG & Co KGaA, EUROSETS, Fisher & Paykel Healthcare Limited, F. Hoffmann-La Roche Ltd, Getinge AB, LivaNova PLC, Pfizer Inc.
Most people who have ARDS are already in the hospital getting better following an injury or receiving treatment.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
